202 related articles for article (PubMed ID: 12088507)
1. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates.
Attucci S; Korkmaz B; Juliano L; Hazouard E; Girardin C; Brillard-Bourdet M; Réhault S; Anthonioz P; Gauthier F
Biochem J; 2002 Sep; 366(Pt 3):965-70. PubMed ID: 12088507
[TBL] [Abstract][Full Text] [Related]
2. Measurement of neutrophil elastase, proteinase 3, and cathepsin G activities using intramolecularly quenched fluorogenic substrates.
Korkmaz B; Attucci S; Epinette C; Pitois E; Jourdan ML; Juliano L; Gauthier F
Methods Mol Biol; 2012; 844():125-38. PubMed ID: 22262439
[TBL] [Abstract][Full Text] [Related]
3. New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops.
Réhault S; Brillard-Bourdet M; Juliano MA; Juliano L; Gauthier F; Moreau T
J Biol Chem; 1999 May; 274(20):13810-7. PubMed ID: 10318785
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
5. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G.
Owen CA; Campbell MA; Boukedes SS; Campbell EJ
J Immunol; 1995 Dec; 155(12):5803-10. PubMed ID: 7499869
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
7. [Determination of esterase activity of human and animal serine proteinases using fluorogenic esters of amino acids as substrates].
Kraeva LN; Kokriakov VN; Pozdnev VF; Morozov VI; Usova AA
Biull Eksp Biol Med; 1992 Jun; 113(6):600-1. PubMed ID: 1446026
[TBL] [Abstract][Full Text] [Related]
8. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
Ramaha A; Patston PA
Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
10. Development of sensitive cathepsin G fluorogenic substrate using combinatorial chemistry methods.
Lesner A; Wysocka M; Guzow K; Wiczk W; Legowska A; Rolka K
Anal Biochem; 2008 Apr; 375(2):306-12. PubMed ID: 18261971
[TBL] [Abstract][Full Text] [Related]
11. [Various properties of cathepsin G and elastase from swine peripheral blood neutrophils].
Kraeva LN; Kokriakov VN; Chesnokov IN; Iakovleva MF; Lyzlova SN
Biokhimiia; 1988 Apr; 53(4):655-62. PubMed ID: 3395645
[TBL] [Abstract][Full Text] [Related]
12. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.
Garwicz D; Lennartsson A; Jacobsen SE; Gullberg U; Lindmark A
Haematologica; 2005 Jan; 90(1):38-44. PubMed ID: 15642667
[TBL] [Abstract][Full Text] [Related]
13. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells.
Senior RM; Campbell EJ
J Immunol; 1984 May; 132(5):2547-51. PubMed ID: 6562154
[TBL] [Abstract][Full Text] [Related]
15. Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates.
Korkmaz B; Attucci S; Juliano MA; Kalupov T; Jourdan ML; Juliano L; Gauthier F
Nat Protoc; 2008; 3(6):991-1000. PubMed ID: 18536646
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
18. Defining the substrate specificity of mouse cathepsin P.
Puzer L; Barros NM; Oliveira V; Juliano MA; Lu G; Hassanein M; Juliano L; Mason RW; Carmona AK
Arch Biochem Biophys; 2005 Mar; 435(1):190-6. PubMed ID: 15680921
[TBL] [Abstract][Full Text] [Related]
19. Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein.
Oliva ML; Santomauro-Vaz EM; Andrade SA; Juliano MA; Pott VJ; Sampaio MU; Sampaio CA
Biol Chem; 2001 Jan; 382(1):109-13. PubMed ID: 11258660
[TBL] [Abstract][Full Text] [Related]
20. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
